产品名称
IgG2a Antibody, Mouse, 2.2 mg/mL, Chemicon®
biological source
mouse
antibody form
purified immunoglobulin
clone
monoclonal
manufacturer/tradename
Chemicon®
concentration
2.2 mg/mL
technique(s)
ELISA: suitable
shipped in
dry ice
target post-translational modification
unmodified
Quality Level
General description
Purity: 95% or greater
Physical form
Format: Purified
Purified immunoglobulin. Liquid containing no preservatives.
Preparation Note
Maintain at -20°C in undiluted aliquots for up to 12 months. Do not thaw and refreeze.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Application
Mouse IgG2a Monoclonal Antibody control validated for use in ELISA.
Research Category
Inflammation & Immunology
Inflammation & Immunology
Research Sub Category
Immunoglobulins & Immunology
Immunoglobulins & Immunology
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Martin Bentler et al.
Molecular therapy. Methods & clinical development, 30, 576-592 (2023-09-11)
De novo immune responses are considered major challenges in gene therapy. With the aim to lower innate immune responses directly in cells targeted by adeno-associated virus (AAV) vectors, we equipped the vector capsid with a peptide known to interfere with
A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus.
R H Weisbart, D T Noritake, A L Wong, G Chan, A Kacena, K K Colburn, R H Weisbart et al.
Journal of immunology (Baltimore, Md. : 1950) (1950)
The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer.
Hahn, T; Bradley-Dunlop, DJ; Hurley, LH; Von-Hoff, D; Gately, S; Mary, DL; Lu et al.
BMC Cancer null
Richard H Weisbart et al.
Molecular immunology, 39(13), 783-789 (2003-03-06)
Methods for cell type specific targeted intracellular delivery of proteins in vivo remain limited. A murine monoclonal anti-dsDNA antibody, mAb 3E10, was selectively transported into skeletal muscle cells in vivo. The antibody bound a 200 kDa protein only found in
Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus.
Niinuma, A; Higuchi, M; Takahashi, M; Oie, M; Tanaka, Y; Gejyo, F; Tanaka, N; Sugamura et al.
Journal of virology null
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持